112 related articles for article (PubMed ID: 21459324)
1. Hepatic deficiency in transcriptional cofactor TBL1 promotes liver steatosis and hypertriglyceridemia.
Kulozik P; Jones A; Mattijssen F; Rose AJ; Reimann A; Strzoda D; Kleinsorg S; Raupp C; Kleinschmidt J; Müller-Decker K; Wahli W; Sticht C; Gretz N; von Loeffelholz C; Stockmann M; Pfeiffer A; Stöhr S; Dallinga-Thie GM; Nawroth PP; Diaz MB; Herzig S
Cell Metab; 2011 Apr; 13(4):389-400. PubMed ID: 21459324
[TBL] [Abstract][Full Text] [Related]
2. Up-regulation of microRNA-367 promotes liver steatosis through repressing TBL1 in obese mice.
Li DD; Liu Y; Xue L; Su DY; Pang WY
Eur Rev Med Pharmacol Sci; 2017 Apr; 21(7):1598-1603. PubMed ID: 28429344
[TBL] [Abstract][Full Text] [Related]
3. Dietary capsaicin reduces obesity-induced insulin resistance and hepatic steatosis in obese mice fed a high-fat diet.
Kang JH; Goto T; Han IS; Kawada T; Kim YM; Yu R
Obesity (Silver Spring); 2010 Apr; 18(4):780-7. PubMed ID: 19798065
[TBL] [Abstract][Full Text] [Related]
4. Transgenic expression of mutant peroxisome proliferator-activated receptor gamma in liver precipitates fasting-induced steatosis but protects against high-fat diet-induced steatosis in mice.
Tanaka T; Masuzaki H; Ebihara K; Ogawa Y; Yasue S; Yukioka H; Chusho H; Miyanaga F; Miyazawa T; Fujimoto M; Kusakabe T; Kobayashi N; Hayashi T; Hosoda K; Nakao K
Metabolism; 2005 Nov; 54(11):1490-8. PubMed ID: 16253638
[TBL] [Abstract][Full Text] [Related]
5. SUMOylation of TBL1 and TBLR1 promotes androgen-independent prostate cancer cell growth.
Park SY; Na Y; Lee MH; Seo JS; Lee YH; Choi KC; Choi HK; Yoon HG
Oncotarget; 2016 Jul; 7(27):41110-41122. PubMed ID: 27129164
[TBL] [Abstract][Full Text] [Related]
6. Periostin promotes liver steatosis and hypertriglyceridemia through downregulation of PPARα.
Lu Y; Liu X; Jiao Y; Xiong X; Wang E; Wang X; Zhang Z; Zhang H; Pan L; Guan Y; Cai D; Ning G; Li X
J Clin Invest; 2014 Aug; 124(8):3501-13. PubMed ID: 25003192
[TBL] [Abstract][Full Text] [Related]
7. Menin prevents liver steatosis through co-activation of peroxisome proliferator-activated receptor alpha.
Cheng P; Yang SS; Hu XG; Zhou XY; Zhang YJ; Jin G; Zhou YQ
FEBS Lett; 2011 Nov; 585(21):3403-8. PubMed ID: 22001208
[TBL] [Abstract][Full Text] [Related]
8. Deletion of steroid receptor coactivator-3 gene ameliorates hepatic steatosis.
Ma X; Xu L; Wang S; Cui B; Li X; Xu J; Ning G
J Hepatol; 2011 Aug; 55(2):445-52. PubMed ID: 21184786
[TBL] [Abstract][Full Text] [Related]
9. Purification and functional characterization of the human N-CoR complex: the roles of HDAC3, TBL1 and TBLR1.
Yoon HG; Chan DW; Huang ZQ; Li J; Fondell JD; Qin J; Wong J
EMBO J; 2003 Mar; 22(6):1336-46. PubMed ID: 12628926
[TBL] [Abstract][Full Text] [Related]
10. Reversible SUMOylation of TBL1-TBLR1 regulates β-catenin-mediated Wnt signaling.
Choi HK; Choi KC; Yoo JY; Song M; Ko SJ; Kim CH; Ahn JH; Chun KH; Yook JI; Yoon HG
Mol Cell; 2011 Jul; 43(2):203-16. PubMed ID: 21777810
[TBL] [Abstract][Full Text] [Related]
11. Activation of peroxisome proliferator-activated receptor alpha by dietary fish oil attenuates steatosis, but does not prevent experimental steatohepatitis because of hepatic lipoperoxide accumulation.
Larter CZ; Yeh MM; Cheng J; Williams J; Brown S; dela Pena A; Bell-Anderson KS; Farrell GC
J Gastroenterol Hepatol; 2008 Feb; 23(2):267-75. PubMed ID: 17868330
[TBL] [Abstract][Full Text] [Related]
12. TBL1-TBLR1 and beta-catenin recruit each other to Wnt target-gene promoter for transcription activation and oncogenesis.
Li J; Wang CY
Nat Cell Biol; 2008 Feb; 10(2):160-9. PubMed ID: 18193033
[TBL] [Abstract][Full Text] [Related]
13. Weight-loss-associated induction of peroxisome proliferator-activated receptor-alpha and peroxisome proliferator-activated receptor-gamma correlate with reduced atherosclerosis and improved cardiovascular function in obese insulin-resistant mice.
Verreth W; De Keyzer D; Pelat M; Verhamme P; Ganame J; Bielicki JK; Mertens A; Quarck R; Benhabilès N; Marguerie G; Mackness B; Mackness M; Ninio E; Herregods MC; Balligand JL; Holvoet P
Circulation; 2004 Nov; 110(20):3259-69. PubMed ID: 15533870
[TBL] [Abstract][Full Text] [Related]
14. Mindin/Spondin 2 inhibits hepatic steatosis, insulin resistance, and obesity via interaction with peroxisome proliferator-activated receptor α in mice.
Zhu LH; Wang A; Luo P; Wang X; Jiang DS; Deng W; Zhang X; Wang T; Liu Y; Gao L; Zhang S; Zhang X; Zhang J; Li H
J Hepatol; 2014 May; 60(5):1046-54. PubMed ID: 24445216
[TBL] [Abstract][Full Text] [Related]
15. Novel aspects of PPARalpha-mediated regulation of lipid and xenobiotic metabolism revealed through a nutrigenomic study.
Martin PG; Guillou H; Lasserre F; Déjean S; Lan A; Pascussi JM; Sancristobal M; Legrand P; Besse P; Pineau T
Hepatology; 2007 Mar; 45(3):767-77. PubMed ID: 17326203
[TBL] [Abstract][Full Text] [Related]
16. Methionine restriction prevents the progression of hepatic steatosis in leptin-deficient obese mice.
Malloy VL; Perrone CE; Mattocks DA; Ables GP; Caliendo NS; Orentreich DS; Orentreich N
Metabolism; 2013 Nov; 62(11):1651-61. PubMed ID: 23928105
[TBL] [Abstract][Full Text] [Related]
17. Interleukin 6 alleviates hepatic steatosis and ischemia/reperfusion injury in mice with fatty liver disease.
Hong F; Radaeva S; Pan HN; Tian Z; Veech R; Gao B
Hepatology; 2004 Oct; 40(4):933-41. PubMed ID: 15382116
[TBL] [Abstract][Full Text] [Related]
18. Hepatic fatty acid transporter Cd36 is a common target of LXR, PXR, and PPARgamma in promoting steatosis.
Zhou J; Febbraio M; Wada T; Zhai Y; Kuruba R; He J; Lee JH; Khadem S; Ren S; Li S; Silverstein RL; Xie W
Gastroenterology; 2008 Feb; 134(2):556-67. PubMed ID: 18242221
[TBL] [Abstract][Full Text] [Related]
19. Prosteatotic genes are associated with unsaturated fat suppression of saturated fat-induced hepatic steatosis in C57BL/6 mice.
Geng T; Xia L; Russo S; Kamara D; Cowart LA
Nutr Res; 2015 Sep; 35(9):812-22. PubMed ID: 26277244
[TBL] [Abstract][Full Text] [Related]
20. Liver-specific inhibition of ChREBP improves hepatic steatosis and insulin resistance in ob/ob mice.
Dentin R; Benhamed F; Hainault I; Fauveau V; Foufelle F; Dyck JR; Girard J; Postic C
Diabetes; 2006 Aug; 55(8):2159-70. PubMed ID: 16873678
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
